« Return to News | Drug Sponsors

Lundbeck to simplify commercial structure

Friday, June 21, 2013 01:30 PM

Global pharmaceutical Lundbeck has plans to optimize its commercial structure in order to launch new medicines, through increased alignment across countries and improved competencies and investments in areas such as market access.   

This initiative follows Lundbeck's establishment of a flexible commercial organization in Europe last year. Earlier initiatives include the Decisions Now program and the optimizations of Lundbeck's R&D activities.

Lundbeck will divide its commercial operations into six regions: Europe, U.S., Canada, Asia, Latin America and Middle East & Global Distribution. Lundbeck plans to simplify the commercial structure in Europe by organizing its more than 30 affiliates in 10 business units.

The proposed establishment of such business units in Europe will enable Lundbeck to improve competencies in areas such as market access, marketing and medical affairs. Activities will be aligned across countries, duplication of activities can be eliminated and the general complexity of the business can be minimized.

"We want the best possible set-up to ensure the transition of our product portfolio through successful launches of new medicines. With this plan we will have the focus, the structure and the competencies in place to achieve that," said Ole Chrintz, senior vice president, international markets and Europe at Lundbeck.

The restructure could lead to a reduction of 50 to 55 positions in Europe.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.